SURGICAL — Sales to customers (Note 9)
Johnson & Johnson SURGICAL — Sales to customers (Note 9) decreased by 3.6% to $396.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $361.00M to $396.00M. Over 4 years (FY 2021 to FY 2025), SURGICAL — Sales to customers (Note 9) shows an upward trend with a 5.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market adoption or successful product launches within the surgical portfolio, while a decrease may signal competitive pressure or reduced demand for surgical procedures.
Detailed definition
This metric represents the total revenue generated from the sale of surgical products and medical devices to external cu...
Peer comparison
Comparable to segment-specific net revenue figures reported by other diversified medical device and healthcare conglomerates.
jnj_segment_surgical_sales_to_customers_note_9Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $314.00M | $308.00M | $338.00M | $347.00M | $347.00M | $298.00M | $314.00M | $347.00M | $369.00M | $328.00M | $326.00M | $348.00M | $367.00M | $333.00M | $365.00M | $361.00M | $403.00M | $383.00M | $411.00M | $396.00M |
| QoQ Change | — | -1.9% | +9.7% | +2.7% | +0.0% | -14.1% | +5.4% | +10.5% | +6.3% | -11.1% | -0.6% | +6.7% | +5.5% | -9.3% | +9.6% | -1.1% | +11.6% | -5.0% | +7.3% | -3.6% |
| YoY Change | — | — | — | — | +10.5% | -3.2% | -7.1% | +0.0% | +6.3% | +10.1% | +3.8% | +0.3% | -0.5% | +1.5% | +12.0% | +3.7% | +9.8% | +15.0% | +12.6% | +9.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's surgical — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported surgical — sales to customers (note 9) of $396.00M in Q1 2026.
- How has Johnson & Johnson's surgical — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's surgical — sales to customers (note 9) increased by 9.7% year-over-year, from $361.00M to $396.00M.
- What is the long-term trend for Johnson & Johnson's surgical — sales to customers (note 9)?
- Over 4 years (2021 to 2025), Johnson & Johnson's surgical — sales to customers (note 9) has grown at a 5.7% compound annual growth rate (CAGR), from $1.25B to $1.56B.
- What does surgical — sales to customers (note 9) mean?
- The total revenue earned from selling surgical products to customers.